Pursuant to the provisions of Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parmax Pharma has enclosed the Annual Report of the Company for the Financial Year 2022-23.
The above information is a part of company’s filings submitted to BSE.